PITTSBURGH, Dec. 17, 2014 /PRNewswire/ -- Mylan Inc.
(Nasdaq: MYL), one of the world's leading generic and specialty
pharmaceutical companies, today announced that the Company will
present at the J.P. Morgan 33rd Annual Healthcare
Conference on Tuesday Jan. 13, 2015,
in San Francisco.
The presentation is scheduled to begin at 7:30 p.m. ET on Tuesday
Jan. 13, 2015. Interested parties can access a live
webcast of the presentation via the investor relations section of
Mylan's Web site at www.mylan.com/investor. An archived version
will also be available following the live presentation and can be
accessed at the same location for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in health care. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 1,300 generic pharmaceuticals and several
brand medications. In addition, we offer a wide range of
antiretroviral therapies, upon which approximately 40% of HIV/AIDS
patients in developing countries depend. We also operate one of the
largest active pharmaceutical ingredient manufacturers and
currently market products in approximately 140 countries and
territories. Our workforce of more than 20,000 people is dedicated
to improving the customer experience and increasing pharmaceutical
access to consumers around the world. Learn more at mylan.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-jp-morgan-33rd-annual-healthcare-conference-300011113.html
SOURCE Mylan Inc.